APO RESEARCH · REPORT
Pharmaceutical Contract Manufacturing and Contract
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Product & engineering
Understand the product.
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Selected research
Industry Growth & Trends
Global Pharmaceutical Contract Manufacturing and Contract Industry Growth and Trends Forecast to 2032
Market perspective
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
According to APO Research, the global Pharmaceutical Contract Manufacturing and Contract market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Pharmaceutical Contract Manufacturing and Contract market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Contract Manufacturing and Contract market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Contract Manufacturing and Contract market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Contract Manufacturing and Contract.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Contract Manufacturing and Contract market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Contract Manufacturing and Contract Market by Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Pharmaceutical Contract Manufacturing and Contract Segment by Type
Oral
Injectable
API
Other
Pharmaceutical Contract Manufacturing and Contract Segment by Application
Small Medium Enterprise
Large Enterprise
Pharmaceutical Contract Manufacturing and Contract Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Manufacturing and Contract market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Manufacturing and Contract and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Manufacturing and Contract.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injectable
- API
- Other
Applications
- Small Medium Enterprise
- Large Enterprise
Companies covered
- Catalent
- Thermo Fisher Scientific
- Lonza
- Boehringer Ingelheim
- Fareva
- Recipharm
- Aenova
- AbbVie
- Baxter
- Nipro Corp
- Sopharma
- Famar
- Vetter
- Shandong Xinhua
- Piramal
- Mylan
- Dr. Reddy’s
- Zhejiang Hisun
- Zhejiang Huahai
- Jubilant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2021-2032)
- 1.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2021-2026)
- 1.4.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
- 1.5.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (2021-2032)
2 Pharmaceutical Contract Manufacturing and Contract Market by Type
- 2.1 Type Introduction
- 2.1.1 Oral
- 2.1.2 Injectable
- 2.1.3 API
- 2.1.4 Other
- 2.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type
- 2.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions
- 2.3.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Contract Manufacturing and Contract Market by Application
- 3.1 Type Introduction
- 3.1.1 Small Medium Enterprise
- 3.1.2 Large Enterprise
- 3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application
- 3.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions
- 3.3.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmaceutical Contract Manufacturing and Contract Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
- 4.2 Pharmaceutical Contract Manufacturing and Contract Industry Drivers
- 4.3 Pharmaceutical Contract Manufacturing and Contract Industry Opportunities and Challenges
- 4.4 Pharmaceutical Contract Manufacturing and Contract Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmaceutical Contract Manufacturing and Contract Revenue (2021-2026)
- 5.2 Global Pharmaceutical Contract Manufacturing and Contract Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmaceutical Contract Manufacturing and Contract Key Company Headquarters & Area Served
- 5.4 Global Pharmaceutical Contract Manufacturing and Contract Company, Product Type & Application
- 5.5 Global Pharmaceutical Contract Manufacturing and Contract Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmaceutical Contract Manufacturing and Contract Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmaceutical Contract Manufacturing and Contract Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmaceutical Contract Manufacturing and Contract Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Catalent
- 6.1.1 Catalent Company Information
- 6.1.2 Catalent Business Overview
- 6.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Catalent Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.1.5 Catalent Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 Lonza
- 6.3.1 Lonza Company Information
- 6.3.2 Lonza Business Overview
- 6.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Lonza Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.3.5 Lonza Recent Developments
- 6.4 Boehringer Ingelheim
- 6.4.1 Boehringer Ingelheim Company Information
- 6.4.2 Boehringer Ingelheim Business Overview
- 6.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.4.5 Boehringer Ingelheim Recent Developments
- 6.5 Fareva
- 6.5.1 Fareva Company Information
- 6.5.2 Fareva Business Overview
- 6.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fareva Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.5.5 Fareva Recent Developments
- 6.6 Recipharm
- 6.6.1 Recipharm Company Information
- 6.6.2 Recipharm Business Overview
- 6.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Recipharm Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.6.5 Recipharm Recent Developments
- 6.7 Aenova
- 6.7.1 Aenova Company Information
- 6.7.2 Aenova Business Overview
- 6.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Aenova Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.7.5 Aenova Recent Developments
- 6.8 AbbVie
- 6.8.1 AbbVie Company Information
- 6.8.2 AbbVie Business Overview
- 6.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 AbbVie Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.8.5 AbbVie Recent Developments
- 6.9 Baxter
- 6.9.1 Baxter Company Information
- 6.9.2 Baxter Business Overview
- 6.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Baxter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.9.5 Baxter Recent Developments
- 6.10 Nipro Corp
- 6.10.1 Nipro Corp Company Information
- 6.10.2 Nipro Corp Business Overview
- 6.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.10.5 Nipro Corp Recent Developments
- 6.11 Sopharma
- 6.11.1 Sopharma Company Information
- 6.11.2 Sopharma Business Overview
- 6.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sopharma Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.11.5 Sopharma Recent Developments
- 6.12 Famar
- 6.12.1 Famar Company Information
- 6.12.2 Famar Business Overview
- 6.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Famar Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.12.5 Famar Recent Developments
- 6.13 Vetter
- 6.13.1 Vetter Company Information
- 6.13.2 Vetter Business Overview
- 6.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Vetter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.13.5 Vetter Recent Developments
- 6.14 Shandong Xinhua
- 6.14.1 Shandong Xinhua Company Information
- 6.14.2 Shandong Xinhua Business Overview
- 6.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.14.5 Shandong Xinhua Recent Developments
- 6.15 Piramal
- 6.15.1 Piramal Company Information
- 6.15.2 Piramal Business Overview
- 6.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Piramal Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.15.5 Piramal Recent Developments
- 6.16 Mylan
- 6.16.1 Mylan Company Information
- 6.16.2 Mylan Business Overview
- 6.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Mylan Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.16.5 Mylan Recent Developments
- 6.17 Dr. Reddy’s
- 6.17.1 Dr. Reddy’s Company Information
- 6.17.2 Dr. Reddy’s Business Overview
- 6.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.17.5 Dr. Reddy’s Recent Developments
- 6.18 Zhejiang Hisun
- 6.18.1 Zhejiang Hisun Company Information
- 6.18.2 Zhejiang Hisun Business Overview
- 6.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.18.5 Zhejiang Hisun Recent Developments
- 6.19 Zhejiang Huahai
- 6.19.1 Zhejiang Huahai Company Information
- 6.19.2 Zhejiang Huahai Business Overview
- 6.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.19.5 Zhejiang Huahai Recent Developments
- 6.20 Jubilant
- 6.20.1 Jubilant Company Information
- 6.20.2 Jubilant Business Overview
- 6.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Jubilant Pharmaceutical Contract Manufacturing and Contract Product Portfolio
- 6.20.5 Jubilant Recent Developments
7 North America
- 7.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
- 7.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
- 8.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
- 10.3 South America Pharmaceutical Contract Manufacturing and Contract Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst